First Results of CureVac Covid-19 Vaccine Trial Expected in 2 Months, Says Report

FILE PHOTO: An worker of German biopharmaceutical corporate CureVac, demonstrates analysis workflow on a vaccine for the coronavirus (COVID-19) illness at a laboratory in Tuebingen, Germany, March 12, 2020. Image taken on March 12, 2020. REUTERS/Andreas Gebert/Document Photograph